69 related articles for article (PubMed ID: 20105109)
21. [Study on the expression of HSP70 and HSP90beta in nasopharyngeal carcinoma and the clinical significance].
Liu T; Liang C; Tian L; Wei Y; Zhao J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):640-2, 645. PubMed ID: 16248461
[TBL] [Abstract][Full Text] [Related]
22. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
[TBL] [Abstract][Full Text] [Related]
23. MASPIN subcellular localization and expression in oral cavity squamous cell carcinoma.
Marioni G; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Stramare R; Facco E; Staffieri A; Blandamura S
Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S97-104. PubMed ID: 18236066
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
[TBL] [Abstract][Full Text] [Related]
25. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
26. Nasopharyngeal carcinoma: recognizing it early in children with otitis media with effusion.
Noorizan Y; Chew YK; Khir A; Brito-Mutunayagam S
Med J Malaysia; 2008 Aug; 63(3):261-2. PubMed ID: 19248706
[TBL] [Abstract][Full Text] [Related]
27. MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence.
Marioni G; Koussis H; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Scola A; Ottaviano G; de Filippis C; Jirillo A; Staffieri A; Blandamura S
Acta Otolaryngol; 2009 Jul; 129(7):786-92. PubMed ID: 18819022
[TBL] [Abstract][Full Text] [Related]
28. Pediatric nasopharyngeal carcinoma: better prognosis and increased c-Kit expression as compared to adults.
Bar-Sela G; Ben Arush MW; Sabo E; Kuten A; Minkov I; Ben-Izhak O
Pediatr Blood Cancer; 2005 Sep; 45(3):291-7. PubMed ID: 15558705
[TBL] [Abstract][Full Text] [Related]
29. Overproduction of cyclin D1 is dependent on activated mTORC1 signal in nasopharyngeal carcinoma: implication for therapy.
Huang XM; Dai CB; Mou ZL; Wang LJ; Wen WP; Lin SG; Xu G; Li HB
Cancer Lett; 2009 Jun; 279(1):47-56. PubMed ID: 19203829
[TBL] [Abstract][Full Text] [Related]
30. P53 overexpression in nasopharyngeal carcinoma.
Agaoglu FY; Dizdar Y; Dogan O; Alatli C; Ayan I; Savci N; Tas S; Dalay N; Altun M
In Vivo; 2004; 18(5):555-60. PubMed ID: 15523893
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
[TBL] [Abstract][Full Text] [Related]
32. [The expression and potentially clinical significance of heparanase in nasopharyngeal carcinoma].
Zhu G; Xiao D; Wu S; Yuan Y; Wang L; Lü C
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):979-81. PubMed ID: 19157148
[TBL] [Abstract][Full Text] [Related]
33. Maspin expression and its clinical significance in non-small cell lung cancer.
Nakagawa M; Katakura H; Adachi M; Takenaka K; Yanagihara K; Otake Y; Wada H; Tanaka F
Ann Surg Oncol; 2006 Nov; 13(11):1517-23. PubMed ID: 17009165
[TBL] [Abstract][Full Text] [Related]
34. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of Bcl-2 oncoprotein in EBV-associated nasopharyngeal carcinoma correlated to histological type and survival.
Vera-Sempere FJ; Burgos JS; Botella MS; Morera C
Histol Histopathol; 1997 Jan; 12(1):9-18. PubMed ID: 9046038
[TBL] [Abstract][Full Text] [Related]
36. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
37. Maspin expression in oral squamous cell carcinoma.
Iezzi G; Piattelli A; Rubini C; Goteri G; Artese L; Perrotti V; Carinci F
J Craniofac Surg; 2007 Sep; 18(5):1039-43. PubMed ID: 17912078
[TBL] [Abstract][Full Text] [Related]
38. [Effects on distant metastasis of misdiagnosis of nasopharyngeal carcinoma].
Mo L; Kuang G; Huang G; Yang R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1124-6. PubMed ID: 18330260
[TBL] [Abstract][Full Text] [Related]
39. Nasopharyngeal carcinoma.
Chidlow JH; DeSanto LW
Minn Med; 1972 Jul; 55(7):619-22. PubMed ID: 5031892
[No Abstract] [Full Text] [Related]
40. Nasopharyngeal carcinoma: methods of presentation.
Skinner DW; Van Hasselt CA
Ear Nose Throat J; 1990 Apr; 69(4):237-40. PubMed ID: 2351084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
